Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
40.28
+0.90 (2.29%)
At close: Jun 27, 2025, 2:57 PM CST
Shanghai OPM Biosciences Revenue
Shanghai OPM Biosciences had revenue of 83.68M CNY in the quarter ending March 31, 2025, with 4.98% growth. This brings the company's revenue in the last twelve months to 301.21M, up 18.16% year-over-year. In the year 2024, Shanghai OPM Biosciences had annual revenue of 297.24M with 22.26% growth.
Revenue (ttm)
301.21M
Revenue Growth
+18.16%
P/S Ratio
17.09
Revenue / Employee
918.34K
Employees
328
Market Cap
5.15B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |